Pretransplant hepatomegaly is linked to relapse in patients with leukemia and myelodysplastic syndrome not in remission
In conclusion, our findings suggest that the LI may be a risk factor for relapse in NonCR patients after allo-HCT.PMID:38252235 | DOI:10.1007/s12185-023-03707-7
Source: International Journal of Hematology - Category: Hematology Authors: Yusuke Okayama Naonori Harada Yosuke Makuuchi Masatomo Kuno Teruhito Takakuwa Hiroshi Okamura Asao Hirose Mika Nakamae Mitsutaka Nishimoto Yasuhiro Nakashima Hideo Koh Masayuki Hino Hirohisa Nakamae Source Type: research
More News: Acute Leukemia | Cancer & Oncology | Hematology | Hepatomegaly | Leukemia | Liver | Liver Transplant | Myelodysplastic Syndrome | Statistics | Stem Cell Therapy | Stem Cells | Study | Transplants | Urology & Nephrology